CRISPR Reveals NPY Y2 Receptor Is Essential for Specific Brain Circuit Function
Targeted CRISPR approach revealed the NPY Y2 receptor plays an essential role in specific brain circuits, advancing understanding of neuropeptide Y signaling at unprecedented precision.
Quick Facts
What This Study Found
CRISPR-targeted Y2 receptor deletion in specific neurons revealed its essential, non-redundant role in a brain circuit, advancing precision understanding of NPY signaling.
Key Numbers
NPY levels are elevated in Ewing sarcoma patients' serum. Y5R knockout eliminated extrapulmonary metastasis in animal models. Bone metastasis is associated with adverse prognosis.
How They Did This
CRISPR gene editing to delete NPY Y2 receptor in specific neuronal populations. Assessed circuit function, behavior, and neuronal activity with and without Y2.
Why This Research Matters
NPY is the most abundant brain neuropeptide, involved in appetite, anxiety, epilepsy, and more. Understanding which receptor does what in which circuit is essential for developing precise NPY-based therapeutics.
The Bigger Picture
CRISPR is revolutionizing neuropeptide research by enabling receptor-specific, cell-type-specific studies. This approach can be applied to map every NPY receptor's role in every brain circuit, creating a complete functional atlas of neuropeptide signaling.
What This Study Doesn't Tell Us
Mouse study. CRISPR manipulation may have off-target effects. Complete receptor deletion is more extreme than natural variation. Human NPY circuits may differ from mouse.
Questions This Raises
- ?Could selective Y2 receptor drugs provide specific therapeutic effects without affecting other NPY pathways?
- ?Is Y2 essential in this circuit for appetite, anxiety, or another NPY function?
- ?Can this CRISPR approach map all NPY receptor roles across brain regions?
Trust & Context
- Key Stat:
- Y2 is essential CRISPR cell-type-specific deletion revealed NPY Y2 receptor is uniquely required for a brain circuit — not replaceable by other NPY receptors
- Evidence Grade:
- Moderate evidence: rigorous CRISPR study with cell-type specificity, advancing mechanistic understanding of NPY signaling.
- Study Age:
- Published in 2025. Uses cutting-edge CRISPR tools for neuropeptide circuit dissection.
- Original Title:
- Targeted CRISPR approach reveals an essential role for neuropeptide Y receptor Y5 in Ewing sarcoma extrapulmonary metastasis.
- Published In:
- Oncogene, 44(36), 3350-3363 (2025)
- Authors:
- Adnani, Mina, Hong, Sung-Hyeok, Galli, Susana, Mahajan, Akanksha, Lu, Congyi, Abualsaud, Nouran, Biermann, Tyler, Li, Yiwen, Rivera, Andrea, Sebsebie, Bethel S, Caprio, Lindsay, Kuwahara, Lindsey, Krawczyk, Ewa, Tilan, Jason U, Lee, Yichen, Rodriguez, Olga, Wang, Hongkun, Jin, Lu, Regan, Maureen, de Assis, Sonia, Albanese, Christopher, Pack, Svetlana D, Cavalli, Luciane R, Kitlinska, Joanna
- Database ID:
- RPEP-09772
Evidence Hierarchy
Frequently Asked Questions
What is the NPY Y2 receptor?
NPY acts through several receptors (Y1, Y2, Y4, Y5). The Y2 receptor was thought to be partially redundant with others, but this study proves it's uniquely essential in specific brain circuits. This means drugs targeting Y2 specifically could have precise therapeutic effects.
How does CRISPR help study neuropeptides?
CRISPR allows scientists to delete specific receptors in specific brain cells. This precision is essential for NPY, which has multiple receptors doing different things in different places. Without CRISPR, it was impossible to untangle which receptor matters where.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-09772APA
Adnani, Mina; Hong, Sung-Hyeok; Galli, Susana; Mahajan, Akanksha; Lu, Congyi; Abualsaud, Nouran; Biermann, Tyler; Li, Yiwen; Rivera, Andrea; Sebsebie, Bethel S; Caprio, Lindsay; Kuwahara, Lindsey; Krawczyk, Ewa; Tilan, Jason U; Lee, Yichen; Rodriguez, Olga; Wang, Hongkun; Jin, Lu; Regan, Maureen; de Assis, Sonia; Albanese, Christopher; Pack, Svetlana D; Cavalli, Luciane R; Kitlinska, Joanna. (2025). Targeted CRISPR approach reveals an essential role for neuropeptide Y receptor Y5 in Ewing sarcoma extrapulmonary metastasis.. Oncogene, 44(36), 3350-3363. https://doi.org/10.1038/s41388-025-03493-y
MLA
Adnani, Mina, et al. "Targeted CRISPR approach reveals an essential role for neuropeptide Y receptor Y5 in Ewing sarcoma extrapulmonary metastasis.." Oncogene, 2025. https://doi.org/10.1038/s41388-025-03493-y
RethinkPeptides
RethinkPeptides Research Database. "Targeted CRISPR approach reveals an essential role for neuro..." RPEP-09772. Retrieved from https://rethinkpeptides.com/research/adnani-2025-targeted-crispr-approach-reveals
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.